{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:34:57Z","timestamp":1791315297526,"version":"4.3.1"},"reference-count":30,"publisher":"American Diabetes Association","issue":"12","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,12,1]]},"abstract":"<jats:p>OBJECTIVE\u2014It has been reported that diabetes may increase the risk of cadmium-induced kidney damage. The presence of metallothionein antibody (MT-Ab) increased the susceptibility for tubular damage among cadmium workers. This study focused on the relationships between levels of MT-Ab, urinary cadmium, and kidney function in a Chinese type 2 diabetic population.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014A cross-sectional study was performed on 229 type 2 diabetic patients (92 men and 137 women) who were recruited from two community centers in one district of Shanghai City in China. Information was obtained from interviews, health records, and blood and urine samples.<\/jats:p>\n               <jats:p>RESULTS\u2014Levels of the tubular biomarker \u03b22-microglobulin increased significantly when the levels of MT-Ab and urinary cadmium were elevated in male and female subjects; in contrast, the levels of urinary albumin, a glomerular biomarker, did not display such a pattern. After adjusting for potential confounding covariates, logistic regression showed that the odds ratios (ORs) of tubular dysfunction increased upon 1) increasing the MT-Ab concentration from a low to high level (OR 5.56 [95% CI 2.25\u201313.73]) and 2) increasing the level of urinary cadmium from &amp;lt;1 to \u22651 \u03bcg\/g creatinine (3.34 [1.17\u20139.53]); the OR of patients currently smoking was 3.51 (1.14\u201310.80) relative to that of those who had never smoked.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014This study proves that the presence of MT-Ab can potentiate tubular dysfunction among diabetic subjects and that patients with high MT-Ab levels are more prone to development of tubular damage.<\/jats:p>","DOI":"10.2337\/dc06-1003","type":"journal-article","created":{"date-parts":[[2006,11,27]],"date-time":"2006-11-27T19:22:18Z","timestamp":1164655338000},"page":"2682-2687","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":77,"title":["Plasma Metallothionein Antibody, Urinary Cadmium, and Renal Dysfunction in a Chinese Type 2 Diabetic Population"],"prefix":"10.2337","volume":"29","author":[{"given":"Liang","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Occupational Health, School of Public Health, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijian","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Occupational Health, School of Public Health, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiyi","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Occupational Health, School of Public Health, Fudan University, Shanghai, China"},{"name":"Environmental Medicine, Department of Public Health and Clinical Medicine, Umea\u030a University, Umea\u030a, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Nordberg","sequence":"additional","affiliation":[{"name":"Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar F.","family":"Nordberg","sequence":"additional","affiliation":[{"name":"Environmental Medicine, Department of Public Health and Clinical Medicine, Umea\u030a University, Umea\u030a, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031217593714000_R1","doi-asserted-by":"crossref","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care\u200827: 1047\u20131053, 2004","DOI":"10.2337\/diacare.27.5.1047"},{"key":"2022031217593714000_R2","unstructured":"International Programme on Chemical Safety: Cadmium. In Environmental Health Criteria Document 134. Geneva, International Programme on Chemical Safety, World Health Org., 1992, p. 1\u2013280"},{"key":"2022031217593714000_R3","doi-asserted-by":"crossref","unstructured":"Buchet JP, Lauwerys R, Roels H, Bernard A, Bruaux P, Claeys F, Ducoffre G, de Plaen P, Staessen J, Amery A, et al.: Renal effects of cadmium body burden of the general population. Lancet\u2008336: 699\u2013702, 1990","DOI":"10.1016\/0140-6736(90)92201-R"},{"key":"2022031217593714000_R4","doi-asserted-by":"crossref","unstructured":"Akesson A, Lundh T, Vahter M, Bjellerup P, Lidfeldt J, Nerbrand C, Samsioe G, Stromberg U, Skerfving S: Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect\u2008113: 1627\u20131631, 2005","DOI":"10.1289\/ehp.8033"},{"key":"2022031217593714000_R5","doi-asserted-by":"crossref","unstructured":"Jin T, Frankel BJ: Cadmium-metallothionein nephrotoxicity is increased in genetically diabetic as compared with normal Chinese hamsters. Pharmacol Toxicol\u200879: 105\u2013108, 1996","DOI":"10.1111\/j.1600-0773.1996.tb00251.x"},{"key":"2022031217593714000_R6","doi-asserted-by":"crossref","unstructured":"Jin T, Nordberg GF, Sehlin J, Leffler P, Wu J: The susceptibility of spontaneously diabetic mice to cadmium-metallothionein nephrotoxicity. Toxicology\u200889: 81\u201390, 1994","DOI":"10.1016\/0300-483X(94)90216-X"},{"key":"2022031217593714000_R7","doi-asserted-by":"crossref","unstructured":"Jin T, Nordberg G, Sehlin J, Wallin H, Sandberg S: The susceptibility to nephrotoxicity of streptozotocin-induced diabetic rats subchronically exposed to cadmium chloride in drinking water. Toxicology\u2008142: 69\u201375, 1999","DOI":"10.1016\/S0300-483X(99)00135-3"},{"key":"2022031217593714000_R8","doi-asserted-by":"crossref","unstructured":"Bernard A, Schadeck C, Cardenas A, Buchet JP, Lauwerys R: Potentiation of diabetic glomerulopathy in uninephrectomized rats subchronically exposed to cadmium. Toxicol Lett\u200858: 51\u201357, 1991","DOI":"10.1016\/0378-4274(91)90190-H"},{"key":"2022031217593714000_R9","unstructured":"Nordberg M, Nordberg GF: Toxicological aspects of metallothionein. Cell Mol Biol (Noisy-le-grand)\u200846: 451\u2013463, 2000"},{"key":"2022031217593714000_R10","doi-asserted-by":"crossref","unstructured":"Cai L, Chen S, Evans T, Cherian MG, Chakrabarti S: Endothelin-1-mediated alteration of metallothionein and trace metals in the liver and kidneys of chronically diabetic rats. Int J Exp Diabetes Res\u20083: 193\u2013198, 2002","DOI":"10.1080\/15604280214281"},{"key":"2022031217593714000_R11","doi-asserted-by":"crossref","unstructured":"Chen ML, Failla ML: Metallothionein metabolism in the liver and kidney of the streptozotocin-diabetic rat. Comp Biochem Physiol B\u200890: 439\u2013445, 1988","DOI":"10.1016\/0305-0491(88)90101-0"},{"key":"2022031217593714000_R12","doi-asserted-by":"crossref","unstructured":"Jin T, Nordberg G, Sehlin J, Vesterberg O: Protection against cadmium-metallothionein nephrotoxicity in streptozotocin-induced diabetic rats: role of increased metallothionein synthesis induced by streptozotocin. Toxicology\u2008106: 55\u201363, 1996","DOI":"10.1016\/0300-483X(95)03164-B"},{"key":"2022031217593714000_R13","doi-asserted-by":"crossref","unstructured":"Jin GB, Nakayama H, Shmyhlo M, Inoue S, Kondo M, Ikezawa Z, Ouchi Y, Cyong JC: High positive frequency of antibodies to metallothionein and heat shock protein 70 in sera of patients with metal allergy. Clin Exp Immunol\u2008131: 275\u2013279, 2003","DOI":"10.1046\/j.1365-2249.2003.02074.x"},{"key":"2022031217593714000_R14","doi-asserted-by":"crossref","unstructured":"Chen L, Jin T, Huang B, Chang X, Lei L, Nordberg GF, Nordberg M: Plasma metallothionein antibody and cadmium-induced renal dysfunction in an occupational population in China. Toxicol Sci\u200891: 104\u2013112, 2006","DOI":"10.1093\/toxsci\/kfj053"},{"key":"2022031217593714000_R15","unstructured":"World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999"},{"key":"2022031217593714000_R16","doi-asserted-by":"crossref","unstructured":"Jin T, Nordberg M, Frech W, Dumont X, Bernard A, Ye TT, Kong Q, Wang Z, Li P, Lundstrom NG, Li Y, Nordberg GF: Cadmium biomonitoring and renal dysfunction among a population environmentally exposed to cadmium from smelting in China (ChinaCad). Biometals\u200815: 397\u2013410, 2002","DOI":"10.1023\/A:1020229923095"},{"key":"2022031217593714000_R17","unstructured":"Kjellstrom T: Renal effects. In Cadmium and Health: A Toxicological and Epidemiological Appraisal. Vol. II: Effects and Response. Friberg LEC, Kjellstro\u0308m T, Nordberg GF, Eds. Boca Raton, FL, CRC Press, 1986. p. 21\u2013109"},{"key":"2022031217593714000_R18","doi-asserted-by":"crossref","unstructured":"Schmidt KD, Valeri C, Leslie RDG: Autoantibodies in type 1 diabetes. Clin Chim Acta\u2008354: 35\u201340, 2005","DOI":"10.1016\/j.cccn.2004.11.017"},{"key":"2022031217593714000_R19","doi-asserted-by":"crossref","unstructured":"Piarulli F, Lapolla A, Sartore G, Rossetti C, Bax G, Noale M, Minicuci N, Fiore C, Marchioro L, Manzato E, Fedele D: Autoantibodies against oxidized LDLs and atherosclerosis in type 2 diabetes. Diabetes Care\u200828: 653\u2013657, 2005","DOI":"10.2337\/diacare.28.3.653"},{"key":"2022031217593714000_R20","doi-asserted-by":"crossref","unstructured":"Aviles-Santa L, Maclaren N, Raskin P: Immune-mediated disease and secondary failure to oral therapy in type 2 diabetes mellitus. J Diabetes Complications\u200818: 10\u201317, 2004","DOI":"10.1016\/S1056-8727(02)00253-2"},{"key":"2022031217593714000_R21","doi-asserted-by":"crossref","unstructured":"Hong C-Y, Hughes K, Chia K-S, Ng V, Ling S-L: Urinary \u03b11-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore. Diabetes Care\u200826: 338\u2013342, 2003","DOI":"10.2337\/diacare.26.2.338"},{"key":"2022031217593714000_R22","doi-asserted-by":"crossref","unstructured":"Thomas MC, Burns WC, Cooper ME: Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis\u200812: 177\u2013186, 2005","DOI":"10.1053\/j.ackd.2005.01.008"},{"key":"2022031217593714000_R23","doi-asserted-by":"crossref","unstructured":"Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int\u200856: 1627\u20131637, 1999","DOI":"10.1046\/j.1523-1755.1999.00721.x"},{"key":"2022031217593714000_R24","unstructured":"Ziyadeh FN: Significance of tubulointerstitial changes in diabetic renal disease. Kidney Int Suppl\u200854: S10\u2013S13, 1996"},{"key":"2022031217593714000_R25","doi-asserted-by":"crossref","unstructured":"Nath KA: The tubulointerstitium in progressive renal disease. Kidney Int\u200854: 992\u2013994, 1998","DOI":"10.1046\/j.1523-1755.1998.00079.x"},{"key":"2022031217593714000_R26","doi-asserted-by":"crossref","unstructured":"Thomson SC, Vallon V, Blantz RC: Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol\u2008286: F8\u2013F15, 2004","DOI":"10.1152\/ajprenal.00208.2003"},{"key":"2022031217593714000_R27","doi-asserted-by":"crossref","unstructured":"Orth SR: Smoking and the kidney. J Am Soc Nephrol\u200813: 1663\u20131672, 2002","DOI":"10.1097\/01.ASN.0000018401.82863.FD"},{"key":"2022031217593714000_R28","unstructured":"Righetti M, Sessa A: Cigarette smoking and kidney involvement. J Nephrol\u200814: 3\u20136, 2001"},{"key":"2022031217593714000_R29","doi-asserted-by":"crossref","unstructured":"Sato M, Kondoh M: Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J Exp Med\u2008196: 9\u201322, 2002","DOI":"10.1620\/tjem.196.9"},{"key":"2022031217593714000_R30","doi-asserted-by":"crossref","unstructured":"Lynes MA, Yin X: Metallothionein and anti-metallothionein, complementary elements of cadmium-induced renal disease. Toxicol Sci\u200891: 1\u20133, 2006","DOI":"10.1093\/toxsci\/kfj149"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/29\/12\/2682\/592406\/zdc01206002682.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/29\/12\/2682\/592406\/zdc01206002682.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T18:55:27Z","timestamp":1647111327000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/29\/12\/2682\/26263\/Plasma-Metallothionein-Antibody-Urinary-Cadmium"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,1]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc06-1003","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,1]]}}}